Background and importance: Appendicitis is a common surgical emergency in children and adolescents, yet its global epidemiological trends and burden remain understudied. This study aims to analyze the global burden of appendicitis in children aged 0–19 years from 1990 to 2021. Methods: We extracted data from the Global Burden of Disease 2021 study to analyze the incidence, prevalence, mortality, and disability-adjusted life-years (DALYs) attributable to appendicitis. Age-standardized rates and trends were stratified by sex, age group, region, and Socio-demographic Index (SDI). Results: In 2021, there were 4.53 million new cases of appendicitis and 360 249 DALYs among children and adolescents globally. The highest age-standardized incidence rate (270.38 [95% uncertainty interval {UI}, 180.93–386.54]) was observed in high-SDI regions, while the highest mortality rate (0.23 [95% UI, 0.14–0.35]) occurred in low-SDI regions. From 1990 to 2021, global age-standardized incidence and prevalence rates decreased slightly, while mortality and DALYs declined substantially. However, the age-standardized incidence and prevalence rates began increasing after 2015 and are projected to rise by over 21% by 2040. Frontier analysis highlighted strong performance in Somalia and Niger among low-SDI countries, whereas the United States Virgin Islands, a high-SDI region, exhibited considerable potential for improvement. Conclusions: The burden of appendicitis among children and adolescents remains significant, with pronounced inequalities across SDI levels. Addressing these inequities requires targeted interventions, such as improving surgical infrastructure in low-SDI regions and optimizing resource utilization in high-SDI regions. These findings provide a foundation for evidence-based policies to ensure equitable care for this vulnerable population.
7 March 2026 in European Journal of Surgical Oncology
Background: Female-specific cancers (FSCs) impose substantial burdens on healthcare systems and economies worldwide. The significant impact of these cancers in the United States warrants further investigation. Objective: This study aimed to analyze trends in incidence and mortality rates of six female-specific cancers (breast, cervical, uterine, ovarian, vaginal, and vulvar cancers) among diverse racial and ethnic groups in the United States, and to evaluate the attributable contributions of major risk factors to the cancer death burden as well as their temporal changes. Methods: Incidence and mortality data were obtained from the SEER (22 registry) database, to examine cross-sectional and temporal trends by race/ethnicity. The burden of FSCs attributable to specific risk factors was estimated based on the Global Burden of Disease 2021 database. Results: Between 2017 and 2021, Breast cancer incidence increased across all racial groups, most notably among non-Hispanic White (White) women, while mortality declined. Cervical cancer incidence decreased in most groups but remained stable among American Indians and Alaska Native (AIAN) women. Uterine cancer incidence increased across all racial groups, except for Whites. Incidence and mortality rates for ovarian and vaginal cancers remained stable or decreased, whereas vulvar cancer mortality was highest among White and AIAN women and lowest among non-Hispanic Asian Americans and Pacific Islander (AAPI) women. From 2000 to 2021, risk-attributable deaths decreased for breast, cervical, and ovarian cancers but increased for uterine cancer. Conclusions: Significant sociodemographic disparities and unfavorable trends persist in the incidence and mortality of all six major female-specific cancers, highlighting the importance for effective prevention and intervention strategies.
Background: Dietary risk factors play crucial roles in the carcinogenesis and progression of cancer. However, the global burden of diet-related neoplasms (DRNs) remains underexplored. Methods: Age-standardized disability-adjusted life years (DALYs) and mortality rates for DRNs were extracted from the Global Burden of Disease (GBD) Study 2021. These were categorized by dietary risk, sex, age, and sociodemographic index (SDI) level. Predictions of DALY and mortality trends from 2021 to 2050 were generated via the Bayesian age-period-cohort models. Cross-country inequalities were assessed using the slope index of inequality and the concentration index. Results: In 2021, dietary risk contributed to 16.40 million DALYs and 0.67 million deaths from DRNs, including esophageal, stomach, colon and rectum, tracheal, bronchus, and lung, breast, and prostate cancers. Diets high in red meat and low in whole grains were primary dietary risks for DRNs. Globally, the age-standardized DALY and mortality rates related to DRNs have decreased over the past three decades and are projected to continue to decline until 2050. The DRNs burden is particularly heavy for colon and rectal cancer patients, patients in high and high-middle SDI regions, men, and those aged ≥70 years. Cross-country inequalities reveal that the slope index of inequality rose for DRNs from 262.74 in 1990 to 296.14 in 2021. The concentration index was 0.27 in 1990 and 0.30 in 2021. Conclusion: This study revealed significant variations in the burden of DRNs across different age groups, sexes, regions, and countries, emphasizing the potential for tailored cancer screening strategies targeting populations with higher risks of DRNs.
8 February 2026 in Journal of Gastroenterology and Hepatology